We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Standard Motor (SMP) Acquires Stoneridge's Sensor Business
Read MoreHide Full Article
Standard Motor Products Inc. (SMP - Free Report) recently announced the acquisition of certain assets and liabilities of the particulate matter sensor business of Stoneridge Inc. Notably, Stoneridge’s particulate matter sensor business generates annual revenues of $12-14 million with manufacturing facilities in Lexington, OH and Tallin in Estonia.
Standard Motor will be relocating all production to its existing locations, and is not acquiring any of Stoneridge’s locations or employees. It is expected that the business will be fully integrated within upcoming 12 months.
The buyout of the particulate matter sensor product line from Stoneridge gives Standard Motor access to advanced emissions control technology used in commercial vehicles. Importantly, this technology is a perfect fit for Standard Motor’s strategy of expansion into the original equipment heavy duty market.
Long Island City, NY-based Standard Motor was founded in 1919 and is one of the leading manufacturers, distributors, and marketers of premium automotive replacement parts for engine management and temperature control systems. It primarily focuses on heavy-duty industrial and the original equipment (OE) market.
The company’s Pollak business buyout has enhanced its growth opportunities in OE, heavy duty and commercial vehicle markets, aftermarket distribution, product management, and service areas. Moreover, the company enjoys a strong competitive advantage courtesy of brand recognition and sizeable customer base.
The company reported robust results for fourth-quarter 2020, with adjusted earnings of $1.08 per share on total revenues of $283 million.
However, the automotive aftermarket is highly competitive and Standard Motor faces tough competition in every market it serves. Also, with the technology shift in full swing, equipment manufacturing companies have to develop and upgrade their offerings to remain on par with the evolving trends in the automotive market. The new features and component designs call for abundant capital, time and labor, in turn, resulting in high R&D spending. This is likely to result in high operating costs for the company.
Shares of the company have appreciated 9.4% year to date, compared with the industry’s growth of 12.4%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Standard Motor (SMP) Acquires Stoneridge's Sensor Business
Standard Motor Products Inc. (SMP - Free Report) recently announced the acquisition of certain assets and liabilities of the particulate matter sensor business of Stoneridge Inc. Notably, Stoneridge’s particulate matter sensor business generates annual revenues of $12-14 million with manufacturing facilities in Lexington, OH and Tallin in Estonia.
Standard Motor will be relocating all production to its existing locations, and is not acquiring any of Stoneridge’s locations or employees. It is expected that the business will be fully integrated within upcoming 12 months.
The buyout of the particulate matter sensor product line from Stoneridge gives Standard Motor access to advanced emissions control technology used in commercial vehicles. Importantly, this technology is a perfect fit for Standard Motor’s strategy of expansion into the original equipment heavy duty market.
Long Island City, NY-based Standard Motor was founded in 1919 and is one of the leading manufacturers, distributors, and marketers of premium automotive replacement parts for engine management and temperature control systems. It primarily focuses on heavy-duty industrial and the original equipment (OE) market.
The company’s Pollak business buyout has enhanced its growth opportunities in OE, heavy duty and commercial vehicle markets, aftermarket distribution, product management, and service areas. Moreover, the company enjoys a strong competitive advantage courtesy of brand recognition and sizeable customer base.
The company reported robust results for fourth-quarter 2020, with adjusted earnings of $1.08 per share on total revenues of $283 million.
However, the automotive aftermarket is highly competitive and Standard Motor faces tough competition in every market it serves. Also, with the technology shift in full swing, equipment manufacturing companies have to develop and upgrade their offerings to remain on par with the evolving trends in the automotive market. The new features and component designs call for abundant capital, time and labor, in turn, resulting in high R&D spending. This is likely to result in high operating costs for the company.
Standard Motor, peers of which include Dorman Products (DORM - Free Report) , Genuine Parts Company (GPC - Free Report) and LKQ Corporation (LKQ - Free Report) , currently carries a Zacks Rank of 3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Shares of the company have appreciated 9.4% year to date, compared with the industry’s growth of 12.4%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>